Quantifying and resolving multiple vector transformants in <it>S. cerevisiae </it>plasmid libraries

par Gray Elizabeth C, Scanlon Thomas C, Griswold Karl E
Publié 2009-11-01

Quantifying and resolving multiple vector transformants in S. cerevisiae plasmid libraries

par Scanlon, Thomas C, Gray, Elizabeth C, Griswold, Karl E
Publié 2009

A High-Throughput Screen for Antibiotic Drug Discovery

par Scanlon, Thomas C., Dostal, Sarah M., Griswold, Karl E.
Publié 2013

The monoclonal myth

par Scanlon, Thomas C, Jewell, Heather L, Gray, Elizabeth C, Griswold, Karl E
Publié 2010

Crystal Structure of a Charge Engineered Human Lysozyme Having Enhanced Bactericidal Activity

par Gill, Avinash, Scanlon, Thomas C., Osipovitch, Daniel C., Madden, Dean R., Griswold, Karl E.
Publié 2011

Genetically Enhanced Lysozyme Evades a Pathogen Derived Inhibitory Protein

par Dostal, Sarah M., Fang, Yongliang, Guerrette, Jonathan C., Scanlon, Thomas C., Griswold, Karl E.
Publié dans ACS Chem Biol (2015)

Genetically Engineered Alginate Lyase-PEG Conjugates Exhibit Enhanced Catalytic Function and Reduced Immunoreactivity

par Lamppa, John W., Ackerman, Margaret E., Lai, Jennifer I., Scanlon, Thomas C., Griswold, Karl E.
Publié 2011

Bioengineered Lysozyme Reduces Bacterial Burden and Inflammation in a Murine Model of Mucoid Pseudomonas aeruginosa Lung Infection

par Teneback, Charlotte C., Scanlon, Thomas C., Wargo, Matthew J., Bement, Jenna L., Griswold, Karl E., Leclair, Laurie W.
Publié 2013

Bioengineered lysozyme in combination therapies for Pseudomonas aeruginosa lung infections

par Griswold, Karl E, Bement, Jenna L, Teneback, Charlotte C, Scanlon, Thomas C, Wargo, Matthew J, Leclair, Laurie W
Publié 2014

Enhanced antimicrobial activity of engineered human lysozyme

par Scanlon, Thomas C., Teneback, Charlotte C., Gill, Avinash, Bement, Jenna L., Weiner, Joshua A., Lamppa, John W., Leclair, Laurie W., Griswold, Karl E.
Publié 2010